Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis.
Ho S, Oswald E, Wong HK, Vural A, Yilmaz V, Tüzün E, Türkoğlu R, Straub T, Meinl I, Thaler F, Kümpfel T, Meinl E, Mader S.
Ho S, et al. Among authors: meinl e.
Neurol Neuroimmunol Neuroinflamm. 2023 Jan 26;10(2):e200083. doi: 10.1212/NXI.0000000000200083. Print 2023 Mar.
Neurol Neuroimmunol Neuroinflamm. 2023.
PMID: 36702538
Free PMC article.